Is Halozyme Therapeutics, Inc. (HALO) a Buy, Sell, or Hold?
NASDAQ : HALO
Halozyme Therapeutics, Inc. — Competitors
$83.3 USD
$0.02 (0.02%)
- Volume
- 1.52M
- Average Volume
- 1.84M
- Market Capitalization
- $9.88B
- P/E Ratio
- 28.53
- Dividend Yield
- 0.00%
- Price Target
- $91.50
- Year High
- $84.44
- Year Low
- $58.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.76
HALO vs. The Competition
| Properties | HALO | ABVX | ATR | CAI |
|---|---|---|---|---|
| Market Cap | $9.88B | $9.13B | $8.54B | $4.55B |
| Shares Outstanding | $118.61M | $73.43M | $63.82M | $282.68M |
| P/E Ratio | 28.53 | -22.46 | 23.91 | -10.34 |
| EPS | 2.95 | -4.83 | 5.68 | 0.12 |
| Day Low | 81.21 | 119 | 133.105 | 15.46 |
| Day High | 83.54 | 125.39 | 136.4 | 16.17 |
| Year Low | 58.53 | 67.09 | 103.23 | 14.19 |
| Year High | 84.44 | 148.83 | 158.12 | 42.5 |
| Average Price 50 | 73.7212 | 118.0992 | 122.262 | 16.8496 |
| Average Price 200 | 69.67345 | 116.53515 | 125.2086 | 21.79343 |
| Volume | 1.52M | 1.49M | 492.22K | 4.48M |
| Average Volume | - | - | - | - |